Mark has an M.S. in Microbiology and Immunology and joined the University of Michigan in December 2015 with 18 years of industry experience. He was most recently with Compendia Bioscience, a part of Thermo Fisher Scientific, in the role of Staff Scientist. His work centered on professional service for the pharmaceutical industry involving bioinformatics analysis of genomic data to identify patient populations for oncology therapeutic intervention. Prior to Compendia, Mark conducted drug discovery research as a Senior Scientist with Pfizer, Inc. leading projects from idea through HTS and into lead development.